Renovo
30
0
0
24
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
6.7%
2 terminated/withdrawn out of 30 trials
92.3%
+5.8% vs industry average
7%
2 trials in Phase 3/4
0%
0 of 24 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (30)
Juvista in Scar Revision Surgery of Disfiguring Scars
Role: lead
Prevascar in African Continental Group Scarring
Role: lead
Adaprev in Digital Flexor Tendon Repair
Role: lead
A Trial to Compare the Efficacy of Two Formulations of Avotermin Against Placebo
Role: lead
Exploratory Study of the Efficacy and Safety of Juvista 250ng When Administered Following Excision of Ear Lobe Keloids
Role: lead
Juvista in the Non-surgical Improvement of Existing Scars
Role: lead
Juvista (Avotermin) in Scars Following Varicose Vein Removal
Role: lead
Safety of Juvista When Administered Following Excision of Ear Lobe Keloids
Role: lead
Investigation Into the Safety of Intradermal Juvidex (M6P) Administered to Wounds of Healthy Subjects
Role: lead
Investigation Into the Safety and Scar-improvement Efficacy of Intradermal Juvidex Dosed Once or Three Times
Role: lead
Investigation of the Accelerated Healing and Anti-scarring Potential of Avotermin (Juvista) in Split Skin Graft Donor Sites
Role: lead
Investigation of the Efficacy of Zesteem in Accelerating Early Wound Healing
Role: lead
Investigation Into the Scar Reduction Potential of Prevascar (Interleukin-10)
Role: lead
Safety and Efficacy Study of Avotermin (Juvista) in Female Subjects
Role: lead
Genomic Changes Associated With the Use of Intradermal Avotermin (Juvista) in Small Wounds in Healthy Male Subjects
Role: lead
Safety Study of Repeated, Escalating Doses of Intradermal Avotermin (Juvista)
Role: lead
Investigation of the Safety, Dosing Frequency and Anti-Scarring Potential of Two Concentrations of Intradermal Avotermin (Juvista)
Role: lead
Trial of Juvista (Avotermin) Following Removal of Ear Lobe Keloid Scars
Role: lead
Trial of Zesteem (Estradiol) in Healing of Split Thickness Skin Graft Donor Sites
Role: lead
Efficacy and Safety of Intradermal RN1001 (Avotermin) in Elderly Subjects.
Role: lead